Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Olagunju A 

PROVIDER: S-EPMC7780204 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature